NXG Investment Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-10,311
Closed -$406K 81
2022
Q2
$406K Buy
10,311
+6,616
+179% +$354K 0.04% 78
2022
Q1
$258K Buy
3,695
+238
+7% +$17.4K 0.02% 87
2021
Q4
$269K Sell
3,457
-3,650
-51% -$322K 0.03% 99
2021
Q3
$678K Buy
7,107
+20
+0.3% +$2.11K 0.07% 90
2021
Q2
$881K Sell
7,087
-143
-2% -$17.1K 0.08% 89
2021
Q1
$953K Sell
7,230
-926
-11% -$127K 0.11% 84
2020
Q4
$1.08M Sell
8,156
-436
-5% -$52.7K 0.12% 86
2020
Q3
$876K Buy
8,592
+178
+2% +$15.4K 0.13% 62
2020
Q2
$732K Buy
8,414
+369
+5% +$29.5K 0.08% 74
2020
Q1
$467K Buy
8,045
+769
+11% +$62.4K 0.07% 75
2019
Q4
$673K Buy
7,276
+156
+2% +$13.7K 0.04% 90
2019
Q3
$643K Buy
+7,120
New +$811K 0.03% 90

Other funds holding EXAS

NXG Investment Management's EXAS Position: Q3 2022 in Review

NXG Investment Management sold out of Exact Sciences (EXAS) in Q3 2022, closing a stake of 10,311 shares — an estimated $406K sold.

NXG Investment Management first reported a position in EXAS in Q3 2019 and held it in 12 quarters. The position peaked at $1.08M in Q4 2020. 480 funds tracked by Wall St. Rank hold EXAS as of Q3 2022.

  • NXG Investment Management reported no remaining Exact Sciences position as of Q3 2022 after selling out during the quarter.
  • NXG Investment Management sold 10,311 Exact Sciences shares in Q3 2022, an estimated $406K.
  • NXG Investment Management first reported a position in Exact Sciences in Q3 2019 and held it in 12 quarters.
  • NXG Investment Management's Exact Sciences position peaked at $1.08M in Q4 2020.
  • 480 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2022.

Based on NXG Investment Management's 13F filing for Q3 2022, filed 14 Nov 2022.